Vivian Hernandez-Trujillo, MD, FAAP

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    DBV
    Topic: 
    Food allergy
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/17/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    US World Meds
    Topic: 
    Anaphylaxis
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/17/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Kaleo
    Topic: 
    Anaphylaxis
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/17/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Covis
    Topic: 
    Asthma
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/17/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Takeda
    Topic: 
    Immunodeficiency
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/17/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    CSL
    Topic: 
    Immunodeficiency
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/17/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    National peanut board
    Topic: 
    Peanut allergy
    Date added: 
    05/06/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/17/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Enzyvant
    Topic: 
    Thymic implant
    Date added: 
    05/06/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/17/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Regeneron/Sanofi
    Topic: 
    Asthma
    Date added: 
    05/06/2022
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    05/17/2023
Return to 26th Annual General Pediatric Review & Self-Assessment